PFKM and cancer: Moreover, Klotho inhibits autophagy, inhibits glycolysis (via hexokinase/HK, phosphofructokinase 1/PFK1, PK M2, and PDK1), fatty acid synthesis, and purine metabolism—some specific to cancer cell effects—making it a promising drug target candidate [311,312,313].